Financial Performance - For the three months ended March 31, 2021, the group's unaudited revenue was approximately SGD 5.1 million, an increase of about SGD 273,000 or 5.7% compared to SGD 4.8 million for the same period in 2020[5]. - The group recorded an unaudited loss of approximately SGD 62,000 for the three months ended March 31, 2021, a significant improvement from a loss of SGD 173,000 for the same period in 2020[5]. - Gross profit for the three months ended March 31, 2021, was SGD 1.145 million, compared to SGD 943,000 for the same period in 2020[9]. - Operating profit for the three months ended March 31, 2021, was SGD 50,000, compared to an operating loss of SGD 47,000 for the same period in 2020[9]. - The total comprehensive loss for the three months ended March 31, 2021, was SGD 38,000, compared to a loss of SGD 131,000 for the same period in 2020[11]. - The company reported a basic and diluted loss per share of SGD 0.00 for the three months ended March 31, 2021, compared to a loss of SGD 0.04 for the same period in 2020[11]. - Revenue for the first quarter ended March 31, 2021, was SGD 5,084 thousand, an increase of 5.7% compared to SGD 4,811 thousand in the same period of 2020[20]. - The company reported a loss attributable to equity holders of SGD 3 thousand for the first quarter, an improvement from a loss of SGD 185 thousand in the same period of 2020[35]. - Basic and diluted loss per share for the first quarter was not significant, compared to a loss of 0.04 Singapore cents in the previous year[35]. - The net loss for the same period was approximately SGD 62,000, a significant improvement from a net loss of SGD 173,000 for the three months ended March 31, 2020[43]. Expenses and Costs - Cost of goods sold for the first quarter was SGD 2,077 thousand, a decrease of 2.9% from SGD 2,140 thousand in the previous year[22]. - Employee benefits expenses rose to SGD 1,557 thousand, up 4.2% from SGD 1,495 thousand in the first quarter of 2020[22]. - Research and development expenses significantly increased to SGD 197 thousand, compared to SGD 48 thousand in the same period last year, reflecting a growth of 310.4%[22]. - The group’s administrative expenses decreased to SGD 994,000 for the three months ended March 31, 2021, from SGD 1.125 million for the same period in 2020[9]. - Other income for the three months ended March 31, 2021, was SGD 43,000, down from SGD 254,000 for the same period in 2020[9]. - Interest expenses related to lease liabilities decreased to SGD 45 thousand from SGD 60 thousand in the previous year[23]. - Government grants received increased to SGD 30 thousand from SGD 24 thousand in the same period last year[20]. - The sales cost for the three months ended March 31, 2021, was approximately SGD 3.9 million, with enhanced cost control measures implemented[48]. - Administrative expenses decreased by approximately SGD 131,000 or 11.6% to about SGD 1.0 million for the same period[50]. Dividends and Shareholder Information - The board of directors did not recommend the payment of dividends for the three months ended March 31, 2021[5]. - The company did not declare an interim dividend for the quarter ended March 31, 2021[39]. - As of March 31, 2021, the major shareholder, Tianyun Global Limited, holds 204,000,000 shares, representing 44.35% of the company's total shares[61]. - Ms. Shi Huiling, another major shareholder, owns 30,000,000 shares, accounting for 6.52% of the company's total shares[61]. - The company did not purchase, sell, or redeem any of its listed securities during the three months ending March 31, 2021[62]. Corporate Governance and Compliance - The company has adhered to the corporate governance code as per GEM listing rules, with no non-compliance incidents reported for the three months ending March 31, 2021[75]. - The audit committee, consisting of three independent non-executive directors, has reviewed the unaudited financial information for the three months ending March 31, 2021, ensuring compliance with applicable accounting standards and GEM listing rules[79]. - The chairman and CEO roles are held by the same individual, Mr. Pan, who has been managing the group since 1981, which the board believes is in the best interest of the company and its shareholders[75]. Share Options and Interests - The share option plan adopted on December 19, 2017, allows for a maximum of 40,000,000 shares to be issued, which is 10% of the total issued shares at the time of listing[66]. - No share options were granted during the three months ending March 31, 2021, and there were no unexercised options as of that date[71]. - The company has not disclosed any interests or conflicts of interest among its directors or major shareholders as of the report date[72]. - The company has not reported any insider trading activities related to its share options plan[68]. - The company’s share option plan is valid for ten years from the adoption date unless terminated early by shareholders[68]. - The company’s board of directors has the discretion to determine the eligibility criteria for participants in the share option plan[66]. Business Operations - The company primarily engages in the manufacturing and sale of disposable medical device components and trading of Chinese alcoholic beverages[14]. - The company continues to explore and enhance its product development capabilities despite the impact of COVID-19 on its operations[44]. - The Chinese liquor trading business did not generate any revenue during the three months ended March 31, 2021, but discussions with distributors are ongoing[44]. - The fair value of identifiable net assets of Savour Talent Global Limited at the acquisition date was determined to be SGD 1.938 million[41]. - The acquisition cost for Savour Talent Global Limited was HKD 16 million, with a potential performance bonus not exceeding HKD 48 million[40]. - The company issued 33,333,333 new shares on April 20, 2020, following the achievement of performance targets related to the acquisition of Savour Talent Global Limited[41].
官酝控股(08513) - 2021 Q1 - 季度财报